Barco (Euronext: BAR; Reuters: BARBt.BR; Bloomberg: BAR BB) announced the results for the third quarter ended 30 September 2020 which they described as a “Soft Q3 with mix of recovery and prolonged covid impact”.
Barco CEO, Jan De Witte told us “While total company topline for the 3rd quarter was flat with the 2rd quarter, we saw improvements in Enterprise and indications of economic recovery in EMEA and parts of APAC. Healthcare delivered a softer quarter, but its fundamentals remain solid. In Entertainment, although the global Cinema and Events segments are clearly riding a roller-coaster, Barco’s longer-term growth opportunities remain unchanged. With Clickshare Conference, positive market receptivity is telling us we have the right product at the right time to enable hybrid workplaces, and we are continuing to invest in building awareness.”
“At this point, it is clear that 2020 will prove to be an off-year for the Barco P&L. To put the company back on its path to reaching its long-term financial goals, we are resetting expense levels while continuing to invest in strategic growth initiatives”.
Financial highlights 3Q20
- Orders, versus 3Q19, declined to 157.6 million euro from 275.6 million euro
- Orders, versus 2Q20, increased 8.7%
- Order book as of 30 September 2020 stood at 299.1 million euro, 5.7% below end of June 2020
- Sales, versus 3Q19, declined to 167.4 million euro from 266.9 million euro
- Sales year-to-date decreased 24.7% to 574.7 million euro, compared to the same period a year ago
- Sales, versus 2Q20, were 2.4% lower reflecting a decline in Healthcare sales in the third quarter offset by increases in Entertainment & Enterprise sales
Executive summary 3Q20
The third quarter results continued to reflect varied demand dynamics associated with covid-19 across Barco’s regions and divisions. Although orders and sales were significantly below last year, on a quarter-over-quarter basis, sales were essentially flat, and orders grew.
3Q versus 2Q comparison – Regional breakdown
From a regional perspective, sales grew in EMEA markets and were flat in APAC, reflecting economic pick-up in several end markets. Sales declined in the Americas region where the pace of economic recovery in our end markets lags other regions.
3Q versus 2Q comparison – Divisional breakdown
Divisional results reflect early indications of economic recovery in the Entertainment and Enterprise divisions. Activity in Healthcare was weaker across all segments and most pronounced in the Americas region as customers reset delivery schedules based on hospital spending priorities.
Enterprise sales began to rebound in the third quarter as demonstrated by a solid pick-up for both the Control Rooms and the ClickShare segments. ClickShare sales continued to steadily improve in line with back-to-office trends and the need for solutions that enable hybrid workspaces. Six months after its launch, ClickShare Conference now accounts for 22% of the ClickShare business.
In Entertainment, both the Cinema and the V&H segments contributed to a modest 3% growth in divisional sales versus Q2 on new build activity for cinema in EMEA and with services rebounding as cinemas reopen.
Healthcare reported a slow third quarter, following a very strong first half. As a result, sales year-to-date for Healthcare are now flat. The weak 3Q was driven by short term postponement of investments by hospitals leading to deployment push-outs.
Investing in strategic growth opportunities while adjusting the cost base
The company continues to execute its plan to align both its activity rate and spending with the impacts of the pandemic by resetting indirect cost levels, next to temporary measures and resource redeployments.
In parallel, the company continues to invest in strategic portfolio innovations and to strengthen commercial activities in selected markets and regions in order to further improve its competitive position.
Taking into account the uncertainties associated with the second covid wave, both in terms of its impact on ongoing recovery rates in Europe and delayed recovery in the Americas region, management expects continuous pressure on topline performance.
Given lower volumes, unfavorable mix and continued investments in commercial and innovation strength, we expect a considerable decrease in full year EBITDA margin compared to the first half.